 | • レポートコード：MRC2-11QY04383 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は予防的B型肝炎ウイルスワクチンのグローバル市場について調査・分析したレポートです。種類別（B型肝炎、肝硬変、肝細胞癌、肝不全）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別予防的B型肝炎ウイルスワクチンの競争状況、市場シェア ・世界の予防的B型肝炎ウイルスワクチン市場：種類別市場規模 2015年-2020年（B型肝炎、肝硬変、肝細胞癌、肝不全） ・世界の予防的B型肝炎ウイルスワクチン市場：種類別市場規模予測 2021年-2026年（B型肝炎、肝硬変、肝細胞癌、肝不全） ・世界の予防的B型肝炎ウイルスワクチン市場：用途別市場規模 2015年-2020年（病院、クリニック） ・世界の予防的B型肝炎ウイルスワクチン市場：用途別市場規模予測 2021年-2026年（病院、クリニック） ・北米の予防的B型肝炎ウイルスワクチン市場分析：米国、カナダ ・ヨーロッパの予防的B型肝炎ウイルスワクチン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの予防的B型肝炎ウイルスワクチン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の予防的B型肝炎ウイルスワクチン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの予防的B型肝炎ウイルスワクチン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Merck、Sanofi Pasteur、Novartis、Pfizer、GlaxoSmithKline ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
The main objective of hepatitis B immunization strategies is to prevent chronic hepatitis B virus infection and its serious consequences, including liver cirrhosis and hepatocellular cancer.
The increasing prevalence and incidence of hepatitis B infection is the dominant factor of driving the growth of prophylactic hepatitis B virus vaccines market.
Market Analysis and Insights: Global Prophylactic Hepatitis B Virus Vaccines Market
The global Prophylactic Hepatitis B Virus Vaccines market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Prophylactic Hepatitis B Virus Vaccines Scope and Market Size
Prophylactic Hepatitis B Virus Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Prophylactic Hepatitis B Virus Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Merck
Sanofi Pasteur
Novartis
Pfizer
GlaxoSmithKline
…
Market segment by Type, the product can be split into
Hepatitis B
Liver Cirrhosis
Hepatocellular Carcinoma
Liver Failure
Market segment by Application, split into
Hospitals
Clinics
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Prophylactic Hepatitis B Virus Vaccines Revenue
1.4 Market by Type
1.4.1 Global Prophylactic Hepatitis B Virus Vaccines Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Hepatitis B
1.4.3 Liver Cirrhosis
1.4.4 Hepatocellular Carcinoma
1.4.5 Liver Failure
1.5 Market by Application
1.5.1 Global Prophylactic Hepatitis B Virus Vaccines Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Prophylactic Hepatitis B Virus Vaccines Market Perspective (2015-2026)
2.2 Global Prophylactic Hepatitis B Virus Vaccines Growth Trends by Regions
2.2.1 Prophylactic Hepatitis B Virus Vaccines Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Prophylactic Hepatitis B Virus Vaccines Historic Market Share by Regions (2015-2020)
2.2.3 Prophylactic Hepatitis B Virus Vaccines Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Prophylactic Hepatitis B Virus Vaccines Market Growth Strategy
2.3.6 Primary Interviews with Key Prophylactic Hepatitis B Virus Vaccines Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Prophylactic Hepatitis B Virus Vaccines Players by Market Size
3.1.1 Global Top Prophylactic Hepatitis B Virus Vaccines Players by Revenue (2015-2020)
3.1.2 Global Prophylactic Hepatitis B Virus Vaccines Revenue Market Share by Players (2015-2020)
3.1.3 Global Prophylactic Hepatitis B Virus Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Prophylactic Hepatitis B Virus Vaccines Market Concentration Ratio
3.2.1 Global Prophylactic Hepatitis B Virus Vaccines Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Prophylactic Hepatitis B Virus Vaccines Revenue in 2019
3.3 Prophylactic Hepatitis B Virus Vaccines Key Players Head office and Area Served
3.4 Key Players Prophylactic Hepatitis B Virus Vaccines Product Solution and Service
3.5 Date of Enter into Prophylactic Hepatitis B Virus Vaccines Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Prophylactic Hepatitis B Virus Vaccines Historic Market Size by Type (2015-2020)
4.2 Global Prophylactic Hepatitis B Virus Vaccines Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2015-2020)
5.2 Global Prophylactic Hepatitis B Virus Vaccines Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Prophylactic Hepatitis B Virus Vaccines Market Size (2015-2020)
6.2 Prophylactic Hepatitis B Virus Vaccines Key Players in North America (2019-2020)
6.3 North America Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2015-2020)
6.4 North America Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2015-2020)
7 Europe
7.1 Europe Prophylactic Hepatitis B Virus Vaccines Market Size (2015-2020)
7.2 Prophylactic Hepatitis B Virus Vaccines Key Players in Europe (2019-2020)
7.3 Europe Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2015-2020)
7.4 Europe Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2015-2020)
8 China
8.1 China Prophylactic Hepatitis B Virus Vaccines Market Size (2015-2020)
8.2 Prophylactic Hepatitis B Virus Vaccines Key Players in China (2019-2020)
8.3 China Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2015-2020)
8.4 China Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2015-2020)
9 Japan
9.1 Japan Prophylactic Hepatitis B Virus Vaccines Market Size (2015-2020)
9.2 Prophylactic Hepatitis B Virus Vaccines Key Players in Japan (2019-2020)
9.3 Japan Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2015-2020)
9.4 Japan Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Prophylactic Hepatitis B Virus Vaccines Market Size (2015-2020)
10.2 Prophylactic Hepatitis B Virus Vaccines Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2015-2020)
10.4 Southeast Asia Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2015-2020)
11 India
11.1 India Prophylactic Hepatitis B Virus Vaccines Market Size (2015-2020)
11.2 Prophylactic Hepatitis B Virus Vaccines Key Players in India (2019-2020)
11.3 India Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2015-2020)
11.4 India Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Prophylactic Hepatitis B Virus Vaccines Market Size (2015-2020)
12.2 Prophylactic Hepatitis B Virus Vaccines Key Players in Central & South America (2019-2020)
12.3 Central & South America Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2015-2020)
12.4 Central & South America Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Merck
13.1.1 Merck Company Details
13.1.2 Merck Business Overview
13.1.3 Merck Prophylactic Hepatitis B Virus Vaccines Introduction
13.1.4 Merck Revenue in Prophylactic Hepatitis B Virus Vaccines Business (2015-2020))
13.1.5 Merck Recent Development
13.2 Sanofi Pasteur
13.2.1 Sanofi Pasteur Company Details
13.2.2 Sanofi Pasteur Business Overview
13.2.3 Sanofi Pasteur Prophylactic Hepatitis B Virus Vaccines Introduction
13.2.4 Sanofi Pasteur Revenue in Prophylactic Hepatitis B Virus Vaccines Business (2015-2020)
13.2.5 Sanofi Pasteur Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview
13.3.3 Novartis Prophylactic Hepatitis B Virus Vaccines Introduction
13.3.4 Novartis Revenue in Prophylactic Hepatitis B Virus Vaccines Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 Pfizer
13.4.1 Pfizer Company Details
13.4.2 Pfizer Business Overview
13.4.3 Pfizer Prophylactic Hepatitis B Virus Vaccines Introduction
13.4.4 Pfizer Revenue in Prophylactic Hepatitis B Virus Vaccines Business (2015-2020)
13.4.5 Pfizer Recent Development
13.5 GlaxoSmithKline
13.5.1 GlaxoSmithKline Company Details
13.5.2 GlaxoSmithKline Business Overview
13.5.3 GlaxoSmithKline Prophylactic Hepatitis B Virus Vaccines Introduction
13.5.4 GlaxoSmithKline Revenue in Prophylactic Hepatitis B Virus Vaccines Business (2015-2020)
13.5.5 GlaxoSmithKline Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Prophylactic Hepatitis B Virus Vaccines Key Market Segments
Table 2. Key Players Covered: Ranking by Prophylactic Hepatitis B Virus Vaccines Revenue
Table 3. Ranking of Global Top Prophylactic Hepatitis B Virus Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Prophylactic Hepatitis B Virus Vaccines Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Hepatitis B
Table 6. Key Players of Liver Cirrhosis
Table 7. Key Players of Hepatocellular Carcinoma
Table 8. Key Players of Liver Failure
Table 9. Global Prophylactic Hepatitis B Virus Vaccines Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Prophylactic Hepatitis B Virus Vaccines Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Prophylactic Hepatitis B Virus Vaccines Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Prophylactic Hepatitis B Virus Vaccines Market Share by Regions (2015-2020)
Table 13. Global Prophylactic Hepatitis B Virus Vaccines Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Prophylactic Hepatitis B Virus Vaccines Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Prophylactic Hepatitis B Virus Vaccines Market Growth Strategy
Table 19. Main Points Interviewed from Key Prophylactic Hepatitis B Virus Vaccines Players
Table 20. Global Prophylactic Hepatitis B Virus Vaccines Revenue by Players (2015-2020) (Million US$)
Table 21. Global Prophylactic Hepatitis B Virus Vaccines Market Share by Players (2015-2020)
Table 22. Global Top Prophylactic Hepatitis B Virus Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prophylactic Hepatitis B Virus Vaccines as of 2019)
Table 23. Global Prophylactic Hepatitis B Virus Vaccines by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Prophylactic Hepatitis B Virus Vaccines Product Solution and Service
Table 26. Date of Enter into Prophylactic Hepatitis B Virus Vaccines Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2015-2020) (Million US$)
Table 29. Global Prophylactic Hepatitis B Virus Vaccines Market Size Share by Type (2015-2020)
Table 30. Global Prophylactic Hepatitis B Virus Vaccines Revenue Market Share by Type (2021-2026)
Table 31. Global Prophylactic Hepatitis B Virus Vaccines Market Size Share by Application (2015-2020)
Table 32. Global Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2015-2020) (Million US$)
Table 33. Global Prophylactic Hepatitis B Virus Vaccines Market Size Share by Application (2021-2026)
Table 34. North America Key Players Prophylactic Hepatitis B Virus Vaccines Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Prophylactic Hepatitis B Virus Vaccines Market Share (2019-2020)
Table 36. North America Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2015-2020) (Million US$)
Table 37. North America Prophylactic Hepatitis B Virus Vaccines Market Share by Type (2015-2020)
Table 38. North America Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2015-2020) (Million US$)
Table 39. North America Prophylactic Hepatitis B Virus Vaccines Market Share by Application (2015-2020)
Table 40. Europe Key Players Prophylactic Hepatitis B Virus Vaccines Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Prophylactic Hepatitis B Virus Vaccines Market Share (2019-2020)
Table 42. Europe Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Prophylactic Hepatitis B Virus Vaccines Market Share by Type (2015-2020)
Table 44. Europe Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Prophylactic Hepatitis B Virus Vaccines Market Share by Application (2015-2020)
Table 46. China Key Players Prophylactic Hepatitis B Virus Vaccines Revenue (2019-2020) (Million US$)
Table 47. China Key Players Prophylactic Hepatitis B Virus Vaccines Market Share (2019-2020)
Table 48. China Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2015-2020) (Million US$)
Table 49. China Prophylactic Hepatitis B Virus Vaccines Market Share by Type (2015-2020)
Table 50. China Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2015-2020) (Million US$)
Table 51. China Prophylactic Hepatitis B Virus Vaccines Market Share by Application (2015-2020)
Table 52. Japan Key Players Prophylactic Hepatitis B Virus Vaccines Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Prophylactic Hepatitis B Virus Vaccines Market Share (2019-2020)
Table 54. Japan Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Prophylactic Hepatitis B Virus Vaccines Market Share by Type (2015-2020)
Table 56. Japan Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Prophylactic Hepatitis B Virus Vaccines Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Prophylactic Hepatitis B Virus Vaccines Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Prophylactic Hepatitis B Virus Vaccines Market Share (2019-2020)
Table 60. Southeast Asia Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Prophylactic Hepatitis B Virus Vaccines Market Share by Type (2015-2020)
Table 62. Southeast Asia Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Prophylactic Hepatitis B Virus Vaccines Market Share by Application (2015-2020)
Table 64. India Key Players Prophylactic Hepatitis B Virus Vaccines Revenue (2019-2020) (Million US$)
Table 65. India Key Players Prophylactic Hepatitis B Virus Vaccines Market Share (2019-2020)
Table 66. India Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2015-2020) (Million US$)
Table 67. India Prophylactic Hepatitis B Virus Vaccines Market Share by Type (2015-2020)
Table 68. India Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2015-2020) (Million US$)
Table 69. India Prophylactic Hepatitis B Virus Vaccines Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Prophylactic Hepatitis B Virus Vaccines Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Prophylactic Hepatitis B Virus Vaccines Market Share (2019-2020)
Table 72. Central & South America Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Prophylactic Hepatitis B Virus Vaccines Market Share by Type (2015-2020)
Table 74. Central & South America Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Prophylactic Hepatitis B Virus Vaccines Market Share by Application (2015-2020)
Table 76. Merck Company Details
Table 77. Merck Business Overview
Table 78. Merck Product
Table 79. Merck Revenue in Prophylactic Hepatitis B Virus Vaccines Business (2015-2020) (Million US$)
Table 80. Merck Recent Development
Table 81. Sanofi Pasteur Company Details
Table 82. Sanofi Pasteur Business Overview
Table 83. Sanofi Pasteur Product
Table 84. Sanofi Pasteur Revenue in Prophylactic Hepatitis B Virus Vaccines Business (2015-2020) (Million US$)
Table 85. Sanofi Pasteur Recent Development
Table 86. Novartis Company Details
Table 87. Novartis Business Overview
Table 88. Novartis Product
Table 89. Novartis Revenue in Prophylactic Hepatitis B Virus Vaccines Business (2015-2020) (Million US$)
Table 90. Novartis Recent Development
Table 91. Pfizer Company Details
Table 92. Pfizer Business Overview
Table 93. Pfizer Product
Table 94. Pfizer Revenue in Prophylactic Hepatitis B Virus Vaccines Business (2015-2020) (Million US$)
Table 95. Pfizer Recent Development
Table 96. GlaxoSmithKline Company Details
Table 97. GlaxoSmithKline Business Overview
Table 98. GlaxoSmithKline Product
Table 99. GlaxoSmithKline Revenue in Prophylactic Hepatitis B Virus Vaccines Business (2015-2020) (Million US$)
Table 100. GlaxoSmithKline Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prophylactic Hepatitis B Virus Vaccines Market Share by Type: 2020 VS 2026
Figure 2. Hepatitis B Features
Figure 3. Liver Cirrhosis Features
Figure 4. Hepatocellular Carcinoma Features
Figure 5. Liver Failure Features
Figure 6. Global Prophylactic Hepatitis B Virus Vaccines Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Prophylactic Hepatitis B Virus Vaccines Report Years Considered
Figure 10. Global Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Prophylactic Hepatitis B Virus Vaccines Market Share by Regions: 2020 VS 2026
Figure 12. Global Prophylactic Hepatitis B Virus Vaccines Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Prophylactic Hepatitis B Virus Vaccines Market Share by Players in 2019
Figure 15. Global Top Prophylactic Hepatitis B Virus Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prophylactic Hepatitis B Virus Vaccines as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Prophylactic Hepatitis B Virus Vaccines Revenue in 2019
Figure 17. North America Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
C型肝炎ウイルス（HCV）の世界市場（～2026年） Inflammation of liver causes hepatitis. Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chro…- C型肝炎ウイルス（HCV）抗ウイルス剤の世界市場（～2026年） Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chronic hepatitis infection. Chronic hepatit…
- C型肝炎ウイルスエンベロープタンパク質E2の世界市場（～2026年） Market Analysis and Insights: Global Hepatitis C Virus Envelope Protein E2 Market The global Hepatitis C Virus Envelope Protein E2 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Hepatitis C Virus Envelope Protein E2 S…
- B型肝炎ワクチンの世界市場（～2026年） Market Analysis and Insights: Global Hepatitis B Vaccines Market The global Hepatitis B Vaccines market size is projected to reach US$ 1646.3 million by 2026, from US$ 1597.1 million in 2020, at a CAGR of 2.8%% during 2021-2026. Global Hepatitis B Vaccines Scope and Market Size Hepatitis B Vaccines …
- A型肝炎ウイルス細胞受容体2の世界市場（～2026年） Market Analysis and Insights: Global Hepatitis A Virus Cellular Receptor 2 Market The global Hepatitis A Virus Cellular Receptor 2 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Hepatitis A Virus Cellular Receptor 2 S…